Search results
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 1 day agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...
Pediatrician explains why immunizations are recommended at an early age
KCRG-TV9 Cedar Rapids· 6 days agoThe Centers for Disease Control and Prevention and the American Academy of Pediatrics recommend...
Don’t shred your noncompete yet | Philly Health Insider
Philly.com· 19 hours agoThis week, we break down what a new FTC ban on employment noncompetes means in Philly. Plus, we look...
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 6 days agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 6 days agoMerck noted that the devaluation of the Argentine peso had a 2% impact on sales. Minus that factor,...
More than 10k kids face brain-swelling bug 'if MMR jab uptake doesn't improve’
The US Sun· 7 days agoDr Ava Easton of Encephalitis International said among the 3.4 million children in the UK who were...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 17 hours agoThe company now expects to book adjusted earnings of $2.15 to $2.35 per share for the fiscal year,...
REUTERS NEWS SCHEDULE AT 10:00 a.m. GMT/ 6:00 a.m. ET
Reuters via Yahoo Finance· 18 hours agoInvestors will closely watch any changes to the drugmaker's 2024 forecast, especially for COVID-19 vaccine and antiviral treatment Paxlovid. Fcus will also be on the performance ...
Global measles cases nearly doubled in one year, researchers say
CNN via Yahoo News· 4 days agoThe number of measles cases around the world nearly doubled from 2022 to 2023, researchers say,...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 11 hours agoThe company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an...
